WASHINGTON, Sept. 7, 2021 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that
Vanda's management will participate at the Citi 16th
Annual BioPharma Virtual Conference taking place between September 8 and September 10, 2021. Vanda
management will host investor meetings. Vanda has updated its
corporate presentation, which may be accessed on Vanda's website,
www.vandapharma.com, by clicking on the Investors tab and following
the Corporate Presentation link.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
AJ Jones II
Chief Corporate Affairs and Communications Officer
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
(202) 734-3400
pr@vandapharma.com
View original
content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-the-citi-16th-annual-biopharma-virtual-conference-301370818.html
SOURCE Vanda Pharmaceuticals Inc.